Contract facts
FederalNo full NAICS 325413 intel page yet. Browse NAICS intelligence
CPT ROUTINE AND SAR-COV-2 TESTING is a federal award for Bemidji Area Indian Health Service held by Roche Diagnostics Corp. Estimated value $100K ($100K obligated). Current period of performance ends Sep 24, 2022. Place of performance: OGEMA MN.
Recompete timing
PublicCurrent PoP ended Sep 24, 2022 (1427 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordRoche Diagnostics Corp — $245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75H70521F06010?
75H70521F06010 (CPT routine and sar-cov-2 testing) is a Bemidji Area Indian Health Service award with a potential value of $100K, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75H70521F06010?
Bemidji Area Indian Health Service awarded 75H70521F06010 to Roche Diagnostics Corp (potential $100K).
Who is the incumbent on 75H70521F06010?
Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends Sep 24, 2022.
When does Roche Diagnostics Corp’s 75H70521F06010 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 24, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.